Applied DNA Sciences (APDN) Misses Q3 EPS by 3c

August 10, 2017 4:08 PM

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.61 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

Categories

Earnings Guidance